Inventor · disambiguated record
Christian Stegmann
Also filed as: STEGMANN CHRISTIAN
13 granted patents·6 pending applications·56 citations·filing 2012–2022
90Inventor score
Top patents by PatentIndex Score
19 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0292US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0390US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0490US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0586US9598417B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2014·Granted Mar 21, 2017·11 cites·10 claims
- 0685US10668071B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2018·Granted Jun 2, 2020·3 cites·17 claims
- 0778US10214542B2Modified macrocyclic compoundsBayer Pharma AG·Filed 2016·Granted Feb 26, 2019·2 cites·27 claims
- 0878US9643953B2Substituted benzylpyrazolesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·5 cites·10 claims
- 0977US10717749B2Macrocyclic sulfondiimine compoundsBayer Pharma AG·Filed 2016·Granted Jul 21, 2020·2 cites·17 claims
- 1076US10098883B2(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their useBayer Pharma AG·Filed 2017·Granted Oct 16, 2018·2 cites·12 claims
- 1173US10118930B2Piperidinylpyrazolopyrimidinones and their useBayer Pharma AG·Filed 2015·Granted Nov 6, 2018·3 cites·19 claims
- 1273US9963464B2Macrocyclic compoundsBayer Pharma AG·Filed 2015·Granted May 8, 2018·2 cites·29 claims
- 1370US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1469US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1567US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1657US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1753US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1848US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1939US9512169B23-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicamentsBayer Pharma AG·Filed 2013·Granted Dec 6, 2016·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Christian Stegmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →